A citation-based method for searching scientific literature

Michelle Gray. Adv Exp Med Biol 2019
Times Cited: 16







List of co-cited articles
228 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.
Judit Pallos, Laszlo Bodai, Tamas Lukacsovich, Judith M Purcell, Joan S Steffan, Leslie Michels Thompson, J Lawrence Marsh. Hum Mol Genet 2008
207
12

Network organization of the huntingtin proteomic interactome in mammalian brain.
Dyna I Shirasaki, Erin R Greiner, Ismael Al-Ramahi, Michelle Gray, Pinmanee Boontheung, Daniel H Geschwind, Juan Botas, Giovanni Coppola, Steve Horvath, Joseph A Loo,[...]. Neuron 2012
188
12

Microglial activation in presymptomatic Huntington's disease gene carriers.
Yen F Tai, Nicola Pavese, Alexander Gerhard, Sarah J Tabrizi, Roger A Barker, David J Brooks, Paola Piccini. Brain 2007
282
12

RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA.
Sebastian Aguiar, Bram van der Gaag, Francesco Albert Bosco Cortese. Transl Neurodegener 2017
33
12

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.
Marcela V Karpuj, Mark W Becher, Joe E Springer, Dorothee Chabas, Sawsan Youssef, Rosetta Pedotti, Dennis Mitchell, Lawrence Steinman. Nat Med 2002
312
12

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.
R J Ferrante, O A Andreassen, B G Jenkins, A Dedeoglu, S Kuemmerle, J K Kubilus, R Kaddurah-Daouk, S M Hersch, M F Beal. J Neurosci 2000
377
12

Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease.
Isabelle Arnoux, Michael Willam, Nadine Griesche, Jennifer Krummeich, Hirofumi Watari, Nina Offermann, Stephanie Weber, Partha Narayan Dey, Changwei Chen, Olivia Monteiro,[...]. Elife 2018
45
12

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.
Ji-Yeon Shin, Zhi-Hui Fang, Zhao-Xue Yu, Chuan-En Wang, Shi-Hua Li, Xiao-Jiang Li. J Cell Biol 2005
319
12

Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications.
Bindu D Paul, Solomon H Snyder. Front Mol Neurosci 2019
26
12

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
12

ER stress and the unfolded protein response in neurodegeneration.
Claudio Hetz, Smita Saxena. Nat Rev Neurol 2017
426
12


The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Cody M Wolfe, Nicholas F Fitz, Kyong Nyon Nam, Iliya Lefterov, Radosveta Koldamova. Int J Mol Sci 2018
74
12

Astrocytes in Motor Neuron Diseases.
Chiara F Valori, Giulia Guidotti, Liliana Brambilla, Daniela Rossi. Adv Exp Med Biol 2019
9
22


Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
Jeffrey H Kordower, Yaping Chu, Robert A Hauser, Thomas B Freeman, C Warren Olanow. Nat Med 2008
12

Redox-active iron mediates amyloid-beta toxicity.
C A Rottkamp, A K Raina, X Zhu, E Gaier, A I Bush, C S Atwood, M Chevion, G Perry, M A Smith. Free Radic Biol Med 2001
302
12

Alzheimer disease in 2020.
David M Holtzman, Eckhard Mandelkow, Dennis J Selkoe. Cold Spring Harb Perspect Med 2012
83
12



The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
12

AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease.
J Miniarikova, V Zimmer, R Martier, C C Brouwers, C Pythoud, K Richetin, M Rey, J Lubelski, M M Evers, S J van Deventer,[...]. Gene Ther 2017
48
12

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.
Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
166
12

AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model.
Melvin M Evers, Jana Miniarikova, Stefan Juhas, Astrid Vallès, Bozena Bohuslavova, Jana Juhasova, Helena Kupcova Skalnikova, Petr Vodicka, Ivona Valekova, Cynthia Brouwers,[...]. Mol Ther 2018
81
12

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
393
12

Reversing a model of Parkinson's disease with in situ converted nigral neurons.
Hao Qian, Xinjiang Kang, Jing Hu, Dongyang Zhang, Zhengyu Liang, Fan Meng, Xuan Zhang, Yuanchao Xue, Roy Maimon, Steven F Dowdy,[...]. Nature 2020
160
12

IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.
Carla Lopes, Márcio Ribeiro, Ana I Duarte, Sandrine Humbert, Frederic Saudou, Luís Pereira de Almeida, Michael Hayden, A Cristina Rego. Mol Neurobiol 2014
54
12

Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.
V C Wheeler, J K White, C A Gutekunst, V Vrbanac, M Weaver, X J Li, S H Li, H Yi, J P Vonsattel, J F Gusella,[...]. Hum Mol Genet 2000
344
12

Modulation of striatal projection systems by dopamine.
Charles R Gerfen, D James Surmeier. Annu Rev Neurosci 2011
947
12

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
12

Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
Xiaohong Xu, Yilin Tay, Bernice Sim, Su-In Yoon, Yihui Huang, Jolene Ooi, Kagistia Hana Utami, Amin Ziaei, Bryan Ng, Carola Radulescu,[...]. Stem Cell Reports 2017
126
12

Ageing as a risk factor for neurodegenerative disease.
Yujun Hou, Xiuli Dan, Mansi Babbar, Yong Wei, Steen G Hasselbalch, Deborah L Croteau, Vilhelm A Bohr. Nat Rev Neurol 2019
682
12

Huntington's Disease-Update on Treatments.
Kara J Wyant, Andrew J Ridder, Praveen Dayalu. Curr Neurol Neurosci Rep 2017
60
12

The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.
Heather D E Booth, Warren D Hirst, Richard Wade-Martins. Trends Neurosci 2017
258
12

Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease.
Zheng Wu, Matthew Parry, Xiao-Yi Hou, Min-Hui Liu, Hui Wang, Rachel Cain, Zi-Fei Pei, Yu-Chen Chen, Zi-Yuan Guo, Sambangi Abhijeet,[...]. Nat Commun 2020
60
12

Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.
Jodi L McBride, Mark R Pitzer, Ryan L Boudreau, Brett Dufour, Theodore Hobbs, Sergio R Ojeda, Beverly L Davidson. Mol Ther 2011
165
12

Disease-specific induced pluripotent stem cells.
In-Hyun Park, Natasha Arora, Hongguang Huo, Nimet Maherali, Tim Ahfeldt, Akiko Shimamura, M William Lensch, Chad Cowan, Konrad Hochedlinger, George Q Daley. Cell 2008
12

Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum.
Richard Grondin, Michael D Kaytor, Yi Ai, Peter T Nelson, Deepak R Thakker, Jennifer Heisel, Marcy R Weatherspoon, Janelle L Blum, Eric N Burright, Zhiming Zhang,[...]. Brain 2012
103
12


Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Jeremy M Van Raamsdonk, Jacqueline Pearson, Elizabeth J Slow, Sazzad M Hossain, Blair R Leavitt, Michael R Hayden. J Neurosci 2005
232
12

Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia.
Benedikt Berninger, Marcos R Costa, Ursula Koch, Timm Schroeder, Bernd Sutor, Benedikt Grothe, Magdalena Götz. J Neurosci 2007
268
12

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
144
12

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Stéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, Helene Lepetit, Sonia Lavisse, Philip C Buttery, Colin Watts, James Miskin, Michelle Kelleher, Sarah Deeley,[...]. Lancet 2014
268
12

Directing astroglia from the cerebral cortex into subtype specific functional neurons.
Christophe Heinrich, Robert Blum, Sergio Gascón, Giacomo Masserdotti, Pratibha Tripathi, Rodrigo Sánchez, Steffen Tiedt, Timm Schroeder, Magdalena Götz, Benedikt Berninger. PLoS Biol 2010
318
12

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.
Scott Q Harper, Patrick D Staber, Xiaohua He, Steven L Eliason, Inês H Martins, Qinwen Mao, Linda Yang, Robert M Kotin, Henry L Paulson, Beverly L Davidson. Proc Natl Acad Sci U S A 2005
507
12

Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.
Mahmoud A Pouladi, Yuanyun Xie, Niels Henning Skotte, Dagmar E Ehrnhoefer, Rona K Graham, Jeong Eun Kim, Nagat Bissada, X William Yang, Paolo Paganetti, Robert M Friedlander,[...]. Hum Mol Genet 2010
77
12

Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.
Gabriele Mittermeyer, Chadwick W Christine, Kathryn H Rosenbluth, Suzanne L Baker, Philip Starr, Paul Larson, Paul L Kaplan, John Forsayeth, Michael J Aminoff, Krystof S Bankiewicz. Hum Gene Ther 2012
168
12

Choosing an animal model for the study of Huntington's disease.
Mahmoud A Pouladi, A Jennifer Morton, Michael R Hayden. Nat Rev Neurosci 2013
214
12

Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
Amaal J Starling, Véronique M André, Carlos Cepeda, Marianne de Lima, Scott H Chandler, Michael S Levine. J Neurosci Res 2005
70
12

Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.
Sandra M Holley, Talia Kamdjou, Jack C Reidling, Brian Fury, Dane Coleal-Bergum, Gerhard Bauer, Leslie M Thompson, Michael S Levine, Carlos Cepeda. CNS Neurosci Ther 2018
10
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.